Researchers at Cedars-Smidt Sinai's Heart Institute have confirmed that persons who have had COVID-19 have a higher risk of developing new-onset diabetes, which is the leading cause of cardiovascular disease.
Cedars-Sinai Cancer Center researchers confirmed in a large-scale nationwide survey that pancreatic cancer rates are growing and rising faster among younger women, than males of the same age. Their findings were published in the peer-reviewed journal Gastroenterology.
One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study led by investigators at Cedars-Sinai.
Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic option for patients with these types of tumors.
Terror group Islamic State (ISIS/ISIL) on Sunday claimed responsibility for an attack on a police checkpoint in Egypt's Suez Canal city of Ismailia that killed at least four people, including three police.
Researchers from the Smidt Heart Institute at Cedars-Sinai discovered that women who conceived while following the anti-inflammatory diet had a considerably lower risk of developing preeclampsia during pregnancy in a new study assessing the Mediterranean diet and unfavourable pregnancy outco
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells--cells that control your heartbeat--can "fight back" against therapies to biologically correct abnormal heartbeat rates. The research also uncovered a new way to boost the effectivenes
Researchers at Cedars-Smidt Sinai's Cardiac Institute confirmed the link between a debilitating heart condition and Covid-19, as well as a new link between the same condition and the Covid-19 vaccine.
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
According to new research by Cedars-Sinai investigators, Women with prolonged mental health problems up to three years after childbirth may be suffering from irregular immune system responses
Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are also highly likely to have either underlying heart damage from heart failure and heart attacks, or advanced heart valve disease, or carotid artery disease associate